Study for Safety and Tolerability of TOP1288 Administered Rectally in Healthy and Ulcerative Colitis Subjects

NCT02463045 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
67
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Topivert Pharma Ltd